We can't find the internet
Attempting to reconnect
14438.1;7 PFLS-LS
Profiling of Synthetic Virus-like Nanoparticle Pneumococcal Vaccine Candidates
Résumé
Profiling of Synthetic Virus-like Nanoparticle Pneumococcal Vaccine Candidates
Textes supplémentaires
Abstract
Virometix AG is developing a broad-spectrum pneumococcal vaccine based on its synthetic virus-like particle (SVLP) technology, comprising surface proteins (virulence factors) that are commonly expressed by all pneumococcal serotypes. The vaccine should overcome major shortcomings of the current capsular polysaccharide-based vaccines including limited serotype coverage and high manufacturing complexity. This KTI project should support preclinical profiling of Virometix vaccine candidates in animal models of pneumococcal diseases.
Participants
John A. Robinson
Kontaktperson
robinson@oci.uzh.ch
Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstr. 190 8057 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2012-08-31
- Date de fin
- 2014-09-08
- Coûts totaux approuvés
- CHF 400000.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Nicht aufteilbare / nicht zuteilbare Forschung
Disciplines de recherche
- T490 Biotechnology 100.0%